13D/13G Filings - PASITHEA THERAPEUTICS CORP WT (KTTAW)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-13
10:56 am
Sale
2021-12-3113GPasithea Therapeutics Corp.
KTTA
ALPHA CAPITAL ANSTALT35,750
3.267%
-5,838decrease
(-14.04%)
Filing
History
2021-12-20
4:00 pm
Purchase
2021-11-2913GPasithea Therapeutics Corp.
KTTA
K2 PRINCIPAL FUND L.P.85,000
7.480%
85,000increase
(New Position)
Filing
History
2021-11-04
4:02 pm
Purchase
2021-11-0413GPasithea Therapeutics Corp.
KTTA
ALPHA CAPITAL ANSTALT41,588
6.360%
41,588increase
(New Position)
Filing
History
2021-09-21
7:02 pm
Purchase
2021-09-2113GPasithea Therapeutics Corp.
KTTA
Ionic Ventures LLC37,834
5.800%
37,834increase
(New Position)
Filing
History
Goto Prev, 0, 1